Lu Yao
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Single-Cell Immune Signature and Response to Neoadjuvant Chemotherapy in BRCA1/2-Mutated Breast Cancer.
Journal: JCO precision oncology
Published: November 06, 2025
Risk of second non-breast primary cancer in Chinese breast cancer patients with germline BRCA1/2 pathogenic variants.
Journal: Breast cancer research and treatment
Published: September 22, 2025
Clinical Impact and Genomic Features of Human Epidermal Growth Factor Receptor 2-Low Tumors in BRCA1/2-Mutated Triple-Negative Breast Cancer.
Journal: JCO precision oncology
Published: March 26, 2025
Predicting the likelihood of BRCA1/2 germline pathogenic variants in unselected patients with breast cancer: analysis of more than 10,000 individuals.
Journal: Journal of medical genetics
Published: August 20, 2024
Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: July 03, 2024
Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants.
Journal: Breast cancer research and treatment
Published: January 08, 2024
Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer.
Journal: Cancer biology & medicine
Published: March 02, 2023
Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants.
Journal: Breast cancer research and treatment
Published: January 07, 2023
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 08, 2022
Low Expression of PALB2 is Associated With Poor Survival in Chinese Women With Primary Breast Cancer.
Journal: Clinical breast cancer
Published: July 22, 2022
Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype.
Journal: Breast cancer research and treatment
Published: June 06, 2022
Last Updated: 09/26/2026